Universität zu Köln

2017

Koziolek, M., Beige, J., Wallbach, M., Zenker, D., Henning, G., Halbach, M., Mader, N., Mahfoud, F., Schlieper, G., Schwenger, V., Hausberg, M., Boergel, J., Lodde, M., van der Giet, M., Mueller-Ehmsen, J., Passauer, J., Parmentier, S., Lueders, S., Kraemer, B. K., Buettner, S., Limbourg, F., Jordan, J., Vonend, O., Predel, H. -G. and Reuter, H. (2017). Baroreceptor activation therapy for therapy-resistant hypertension: indications and patient selection. Recommendations of the BAT consensus group 2017. Internist, 58 (10). S. 1114 - 1124. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1289

2014

Stamellou, E., Storz, D., Botov, S., Ntasis, E., Wedel, J., Sollazzo, S., Kraemer, B. K., van Son, W., Seelen, M., Schmalz, H. G. ORCID: 0000-0003-0489-1827, Schmidt, A., Hafner, M. and Yard, B. A. (2014). Different design of enzyme-triggered CO-releasing molecules (ET-CORMs) reveals quantitative differences in biological activities in terms of toxicity and inflammation. Redox Biol., 2. S. 739 - 749. AMSTERDAM: ELSEVIER. ISSN 2213-2317

2013

Romanski, S., Stamellou, E., Jaraba, J. T., Storz, D., Kraemer, B. K., Hafner, M., Amslinger, S., Schmalz, H. G. and Yard, B. A. (2013). Enzyme-triggered CO-releasing molecules (ET-CORMs): Evaluation of biological activity in relation to their structure. Free Radic. Biol. Med., 65. S. 78 - 89. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1873-4596

2012

Stamellou, E., Romanski, S., Amslinger, S., Hafner, M., Kraemer, B. K., Schmalz, H. G. and Yard, B. A. (2012). Enzyme-Triggered CO-Releasing Molecules (ET-CORMs): Structural Entities that Mediate Restricted Cell Specificity for CO Release. Transplantation, 94 (10). S. 1134 - 1135. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1534-6080